Citadel Advisors’s Viveon Health Acquisition Corp. VHAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-15,293
Closed -$153K 14871
2021
Q4
$153K Buy
15,293
+2,801
+22% +$28K ﹤0.01% 12228
2021
Q3
$125K Buy
+12,492
New +$124K ﹤0.01% 12598

Other funds holding VHAQ

Citadel Advisors's VHAQ Position: Q1 2022 in Review

Citadel Advisors sold out of Viveon Health Acquisition Corp. (VHAQ) in Q1 2022, closing a stake of 15,293 shares — an estimated $153K sold.

Citadel Advisors first reported a position in VHAQ in Q3 2021 and held it in 2 quarters. The position peaked at $153K in Q4 2021. 27 funds tracked by Wall St. Rank hold VHAQ as of Q1 2022.

  • Citadel Advisors reported no remaining Viveon Health Acquisition Corp. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 15,293 Viveon Health Acquisition Corp. shares in Q1 2022, an estimated $153K.
  • Citadel Advisors first reported a position in Viveon Health Acquisition Corp. in Q3 2021 and held it in 2 quarters.
  • Citadel Advisors's Viveon Health Acquisition Corp. position peaked at $153K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.